|
|
|
|
|
|
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
||
|
|
||
|
Cancer Pipeline • CTK110 • CTK-100144 • CTK-000147 • Discovery Compounds/10+ Targets Cancer Pipeline The company is building a pipeline of mechanism-based cancer therapeutics, led by the CTK110 series of Aurora kinase inhibitors. The internal effort is currently directed at a selected portfolio of important cancer targets in active screening with our proprietary CE assays and drug source.
|
Cetek Corporation • 508-229-8900 • info@cetek.com Home | About Cetek
| Proprietary
Drug Discovery Technologies | Cancer Drugs & Pipeline
©1998-2006 Cetek Corporation, Marlborough, MA,
USA. |
